0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Nutrition/Metabolic Disorders
 61-80 of 1193 Articles
Original Investigation |  FREE
Mikael Knip, MD, DMSc; Hans K. Åkerblom, MD, DMSc; Dorothy Becker, MB, BCh; et al.
JAMA. 2014;311(22):2279-2287. doi:10.1001/jama.2014.5610.
Includes: Supplemental Content

Review |  FREE
Amisha Wallia, MD, MS; Mark E. Molitch, MD
JAMA. 2014;311(22):2315-2325. doi:10.1001/jama.2014.5951.
Includes: CME, Supplemental Content

Viewpoint | 
David B. Sacks, MB, ChB, FRCPath; W. Garry John, PhD, FRCPath
JAMA. 2014;311(22):2271-2272. doi:10.1001/jama.2014.6342.

Viewpoint | 
Elizabeth R. Seaquist, MD
JAMA. 2014;311(22):2267-2268. doi:10.1001/jama.2014.6451.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;311(22):2265. doi:10.1001/jama.2014.5837.

Viewpoint | 
David S. Ludwig, MD, PhD; Mark I. Friedman, PhD
JAMA. 2014;311(21):2167-2168. doi:10.1001/jama.2014.4133.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;311(21):2162. doi:10.1001/jama.2014.6402.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(21):2229. doi:10.1001/jama.2014.6280.

Viewpoint | 
Chirag J. Patel, PhD; John P. A. Ioannidis, MD, DSc
JAMA. 2014;311(21):2173-2174. doi:10.1001/jama.2014.4129.

Viewpoint | 
Todd Rogers, PhD; Katherine L. Milkman, PhD; Kevin G. Volpp, MD, PhD
JAMA. 2014;311(20):2065-2066. doi:10.1001/jama.2014.3485.

Editorial | 
Graham L. Hall, PhD
JAMA. 2014;311(20):2070-2071. doi:10.1001/jama.2014.5218.

Original Investigation |  FREE
Mario Castro, MD, MPH; Tonya S. King, PhD; Susan J. Kunselman, MA; et al.
JAMA. 2014;311(20):2083-2091. doi:10.1001/jama.2014.5052.
Includes: Supplemental Content

Original Investigation |  FREE
Cindy T. McEvoy, MD, MCR; Diane Schilling, RRT; Nakia Clay, BS; et al.
JAMA. 2014;311(20):2074-2082. doi:10.1001/jama.2014.5217.
Includes: Supplemental Content

Care of the Aging Patient: From Evidence to Action | 
Lawrence B. Oresanya, MD; William L. Lyons, MD; Emily Finlayson, MD
JAMA. 2014;311(20):2110-2120. doi:10.1001/jama.2014.4573.
Includes: Supplemental Content

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(20):2057. doi:10.1001/jama.2014.5762.

JAMA Clinical Challenge | 
Jonathan Lillie, MBBS, BSc, MRCPCH; Finn Coulter, DTM&H, MBBS; Anusha Ganeshalingham, MBChB, FCICM
JAMA. 2014;311(19):2015-2016. doi:10.1001/jama.2014.783.

Viewpoint | 
Alexander Varshavsky, PhD
JAMA. 2014;311(19):1969-1970. doi:10.1001/jama.2014.5549.

news@JAMA | 
JAMA. 2014;311(18):1845. doi:10.1001/jama.2014.4808.

Original Investigation |  FREE
Jennifer G. Robinson, MD, MPH; Bettina S. Nedergaard, MD, PhD; William J. Rogers, MD; et al.
JAMA. 2014;311(18):1870-1883. doi:10.1001/jama.2014.4030.
Includes: Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;311(17):1722. doi:10.1001/jama.2014.4757.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Cardiovascular Risk Prediction Models for People With Severe Mental Illness:  Results From the Prediction and Management of Cardiovascular Risk in People With Severe Mental Illnesses (PRIMROSE) Research Program
David P. J. Osborn, PhD; Sarah Hardoon, PhD; Rumana Z. Omar, PhD; et al.
JAMA Ophthalmology
Original Investigation  | 
Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus:  The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Barbara E. K. Klein, MD, MPH; Chelsea E. Myers, MStat; Kerri P. Howard, MS; et al.
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Surgery
Original Investigation  | 
Prediction of Nocturia Severity in Men:  Nocturnal Urine Overproduction vs Race or Metabolic Risk Factors
Daniel Nassau, MD; Svetlana Avulova, MD; Fara M. Friedman, MD; et al.